These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4327353)

  • 21. The mesorchium vessel reactivity to catecholamines in rats with experimental hypertension.
    Vacek L
    Z Kreislaufforsch; 1966 Jun; 55(6):627-35. PubMed ID: 5989844
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular reactivity of genetically hypertensive rats of the Lyon strain.
    Yoccoz D; Vincent M; Hyvert P; Sassard J
    Eur Heart J; 1982 Oct; 3 Suppl C():9-13. PubMed ID: 7173241
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administration of angiotensin II, but not catecholamines, induces accumulation of lipids in the rat heart.
    Hongo M; Ishizaka N; Furuta K; Yahagi N; Saito K; Sakurai R; Matsuzaki G; Koike K; Nagai R
    Eur J Pharmacol; 2009 Feb; 604(1-3):87-92. PubMed ID: 19109942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre- and postjunctional effects of angiotensin II in hypertension due to adenosine receptor blockade.
    Morato M; Pinho D; Sousa T; Guimarães S; Moura D; Albino-Teixeira A
    Eur J Pharmacol; 2006 Feb; 531(1-3):209-16. PubMed ID: 16438958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations.
    Tatchum-Talom R; Eyster KM; Martin DS
    Can J Physiol Pharmacol; 2005 May; 83(5):413-22. PubMed ID: 15897923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypotensive effects of diltiazem in DOCA/saline hypertensive rats (author's transl)].
    Yamaguchi I; Ikezawa K; Murata S; Narita H; Ikeo T; Sato M
    Nihon Yakurigaku Zasshi; 1979 Mar; 75(2):191-9. PubMed ID: 395050
    [No Abstract]   [Full Text] [Related]  

  • 28. [Medification of the hypertensive effects of catecholamines and of Val-5-angiotensin II in the rat, by the use of several estrogens].
    Limet R; Cession G; Cession-Fossion A
    C R Seances Soc Biol Fil; 1967 Nov; 161(5):1159-61. PubMed ID: 4294564
    [No Abstract]   [Full Text] [Related]  

  • 29. Vascular reactivity in spontaneously hypertensive normotensive and hypotensive rats.
    Dupont J; Sassard J
    Br J Pharmacol; 1974 Feb; 50(2):185-8. PubMed ID: 4371898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiovascular effects of angiotensin II implantates on the intact unanesthesized rat. A contribution to produce a medium-term experimental hypertension].
    Grieger F; Baumann H; Wolf I
    Acta Biol Med Ger; 1972; 28(1):99-107. PubMed ID: 4340176
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic administration of tiapamil prevents hemodynamic alterations accompanying development of high blood pressure in hypertensive rats.
    Hefti F; Gerold M; Holck M
    J Cardiovasc Pharmacol; 1984; 6(6):1192-200. PubMed ID: 6084779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vascular action of angiotensin. Interaction of angiotensin and norepinephrine in the vascular bed].
    Sato R
    Saishin Igaku; 1971 Nov; 26(11):2083-92. PubMed ID: 4334939
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of vascular hypertrophy in early and chronic renovascular hypertension.
    Mistry M; Bing RF; Swales JD; Thurston H
    J Hypertens Suppl; 1983 Dec; 1(2):79-81. PubMed ID: 6599501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous insulin-like growth factor-I receptor antisense treatment reduces angiotensin receptor expression and function in spontaneously hypertensive rats.
    Nguyen TT; Cao N; Short JL; White PJ
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1171-7. PubMed ID: 16751253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Functional and structural reactivity of the arterial vascular system to angiotensin II in spontaneously hypertensive rats].
    Matthias D; Moritz V; Engler E; Schmidt R; Becker CH
    Acta Biol Med Ger; 1981; 40(2):177-87. PubMed ID: 7269988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of extra- and intracellular electrolyte metabolism on vascular reactivity to norepinephrine and angiotensin in patients with hyperthyreosis and in normotensives with familial history of hypertension].
    Wessels F; Losse H
    Arztl Forsch; 1970 Dec; 24(12):349-57. PubMed ID: 4321787
    [No Abstract]   [Full Text] [Related]  

  • 38. Sympathetic and humoral vasoconstrictor responses in deoxycorticosterone hypertension.
    Baum T; Shropshire AT
    Am J Physiol; 1967 Aug; 213(2):499-503. PubMed ID: 4292077
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypertensive activity in protein extracts of swine placenta].
    Tallarida G; Semprini A; Cassone R; Leone G; Critelli G; Condorelli M
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1407-11. PubMed ID: 4320547
    [No Abstract]   [Full Text] [Related]  

  • 40. [Contribution to the study of peripheral vascular reactivity to angiotensin and noradrenaline in the course of hepatic diseases].
    Morandini G; Spanedda M
    Minerva Med; 1966 Jun; 57(47):2175-80. PubMed ID: 4287294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.